Drug target pathway could unlock treatments for diabetes, cancer and COVID

11 May 2021
Visualisation
The protein studied , MyD88, is a key signalling molecule in innate immunity pathways.

Scientists have visualised and investigated a key molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases and potentially even COVID-19.

The international collaboration, featuring University of Queensland researchers, isolated and studied the MyD88 molecule and found the missing link between immune cell receptors and the body’s inflammation response.

Read the full story

Latest